One wonders if they were desperate after the latest TIGIT blow-up (and based on the partnership they already had) https://www.fiercebiotech.com/biotech/roches-tigit-prospect-fails-another-phase-3-lung-cancer-test Either way I'm not complaining.
Market Data 
Markets
AI
